脑震盪市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

2024 年全球脑震盪市场价值为 75 亿美元，预计 2025 年至 2034 年期间将以 4.8% 的复合年增长率强劲增长。这一增长主要得益于创伤性脑损伤发病率的上升、人们对脑震盪管理的认识的不断提高，以及支持诊断和治疗解决方案进步的监管政策。

从细分市场来看，脑震盪市场分为评估和诊断工具以及治疗解决方案。评估和诊断工具部分是 2024 年的主导类别，创收 53 亿美元。该领域的主导地位可归因于诊断技术的快速进步，包括磁振造影（MRI）和电脑断层扫描（CT），这些技术显着提高了脑震盪诊断的准确性。此外，功能性神经成像和扩散张量成像 (DTI) 等创新正在突破诊断能力的界限，可以检测到传统方法可能遗漏的细微脑损伤。

市场也按最终用途进行细分，包括医院、诊断中心和其他医疗机构。医院是 2024 年的主要细分市场，预计到 2034 年将达到 77 亿美元。包括神经科医生、急救专家和復健专家在内的多学科医疗团队的存在确保了全面的护理，从而带来了更好的患者治疗效果。这种综合方法对于有效处理脑震盪病例起着至关重要的作用。

在美国，脑震盪市场在 2024 年的规模为 32 亿美元，预计在整个预测期内的复合年增长率为 4.2%。美国拥有完善的医疗保健基础设施、不断创新的医疗技术以及严格的安全法规，尤其是在体育领域，这些都强调了可靠的脑震盪评估工具的必要性。这些因素导致对先进的脑震盪诊断的需求不断增长。此外，大量的研究投入和便携式诊断设备的日益普及预计将进一步推动该地区市场的成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 创伤性脑损伤不断增加
    • 技术进步
    • 意识不断增强
    • 支持性监管环境
  • 产业陷阱与挑战
    • 先进诊断工具成本高昂
• 成长潜力分析
• 监管格局
• 报销场景
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按类型，2021 年至 2034 年

• 主要趋势
• 评估和诊断工具
  • CT
  • 磁振造影
  • 脑电图
  • 其他评估和诊断工具
• 治疗

第 6 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 诊断中心
• 其他最终用户

第 7 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第八章：公司简介

• Advanced Brain Monitoring
• BIOMÉRIEUX
• BrainScope
• Compumedics
• GE Healthcare
• Healius
• INTEGRA LIFESCIENCES
• Koninklijke Philips NV
• NanoDx
• NIHON KOHDEN
• Oculogica
• Siemens Healthineers

The Global Concussion Market was valued at USD 7.5 billion in 2024 and is expected to experience robust growth at a CAGR of 4.8% from 2025 to 2034. This growth is primarily driven by the rising incidence of traumatic brain injuries, growing awareness about concussion management, and favorable regulatory policies that support advancements in diagnostic and treatment solutions.

In terms of market segments, the concussion market is divided into assessment and diagnostic tools, as well as treatment solutions. The assessment and diagnostic tools segment was the dominant category in 2024, generating USD 5.3 billion. This segment's dominance can be attributed to the rapid advancements in diagnostic technologies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, which have significantly improved concussion diagnosis accuracy. In addition, innovations such as functional neuroimaging and diffusion tensor imaging (DTI) are pushing the boundaries of diagnostic capabilities, allowing for the detection of even subtle brain injuries that traditional methods may miss.

The market is also segmented by end-use, which includes hospitals, diagnostic centers, and other healthcare facilities. Hospitals were the leading segment in 2024 and are expected to reach USD 7.7 billion by 2034. Equipped with state-of-the-art diagnostic technologies, hospitals are the preferred choice for concussion evaluation and treatment. The presence of multidisciplinary healthcare teams, including neurologists, emergency specialists, and rehabilitation experts, ensures comprehensive care, leading to better patient outcomes. This comprehensive approach plays a vital role in managing concussion cases effectively.

In the U.S., the concussion market accounted for USD 3.2 billion in 2024 and is projected to grow at a CAGR of 4.2% throughout the forecast period. The U.S. benefits from a well-established healthcare infrastructure, continuous innovations in medical technologies, and stringent safety regulations, particularly in sports, which emphasize the need for reliable concussion assessment tools. These factors contribute to a growing demand for advanced concussion diagnostics. Additionally, substantial investments in research and the rising adoption of portable diagnostic devices are expected to further fuel market growth in the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising traumatic brain injuries
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Growing awareness
    • 3.2.1.4 Supportive regulatory landscape
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced diagnostics tools
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Assessment and diagnostic tools
  • 5.2.1 CT
  • 5.2.2 MRI
  • 5.2.3 EEG
  • 5.2.4 Other assessment and diagnostic tools
• 5.3 Treatment

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic centers
• 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Advanced Brain Monitoring
• 8.2 BIOMÉRIEUX
• 8.3 BrainScope
• 8.4 Compumedics
• 8.5 GE Healthcare
• 8.6 Healius
• 8.7 INTEGRA LIFESCIENCES
• 8.8 Koninklijke Philips N.V.
• 8.9 NanoDx
• 8.10 NIHON KOHDEN
• 8.11 Oculogica
• 8.12 Siemens Healthineers